by Bhavani Srinivasan | Jun 1, 2023 | Newsletters
EU’s founding father Jean Monnet is widely quoted for saying that “Europe will be forged in crisis and will be the sum of the solutions adopted for those crises”. The regulation of medicines across the Union seems to have followed this logic. Developed in 1965,...
by Bhavani Srinivasan | May 31, 2023 | Opinion
Previous to the publication of the EC proposal to review the EU pharmaceutical legislation, EPHA had called for more transparency of the research and development (R&D) costs for pharmaceutical products. Without clear knowledge of pharmaceutical R&D costs, it...
by European Public Health Alliance | May 31, 2023 | Opinion
By Charlotte Roffiaen, France Assos Santé With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine shortages has become one of the first priorities of the EU and its Member States. This is perfectly reflected in...
by European Public Health Alliance | May 31, 2023 | Opinion
By Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer Leagues (ECL) – @CancerLeagues & @WardRommel | #LetsTalkAccess In Europe, around 2.7 million people are diagnosed with cancer every year – and this number is set to...
by European Public Health Alliance | Apr 26, 2023 | News Release
EPHA welcomes the European Commission’s proposal and calls for a balanced debate so that the legislation adopted serves the needs of all people living across the EU and not just the provision of incentives to the pharmaceutical sector. This lunchtime, the European...
